Cervical cancer screening is one of the most important health checks for women because cervical cancer can be prevented if detected and treated early.
Currently, there are two main screening methods recommended by doctors: ThinPrep (Pap Test) and HPV DNA Test. Each method differs in principles, advantages-disadvantages, and suitability for use.
There are several methods for cervical cancer screening as follows:
1. Pap Smear
This is a traditional screening method used for a long time by collecting cells from the cervix to examine under a microscope to detect cellular changes.
2. ThinPrep Pap Test
A more modern form than the traditional Pap Smear, using Liquid-Based Cytology technology, which provides more accurate results than the traditional method.
3. HPV DNA Test
Detects the DNA of the HPV virus, called HPV DNA testing. This method is highly accurate, nearly 100%, detecting high-risk HPV types that are the main cause of cervical cancer. It is a new, modern, and very accurate method.
4. Colposcopy
When screening results are abnormal, doctors use a special cervical examination device called a COLPOSCOPY to help examine the cervix in more detail.
5. Biopsy
Collecting tissue from abnormal areas for examination to confirm a definitive diagnosis.
Recommendations for cervical cancer screening by age group
- Ages 21–29 years
– It is recommended to have a Cytology test (Pap smear or ThinPrep Pap test) once a year.
– If the first 3 test results are normal, the screening interval can be extended to every 2 years.
- Ages 30 years and above
– You can choose to have ThinPrep and HPV DNA Test, but for more accurate results, both tests should be done together.
– If the results are normal, doctors may recommend extending the screening interval to every 3–5 years.
In-depth! What is ThinPrep (Pap Test)?
ThinPrep or Pap Test is a cervical cancer screening method used for over 70 years. This method collects cells from the cervix and vagina and examines them under a microscope to detect cellular abnormalities.
How it is done
Doctors use a special brush to collect cell samples from the cervix, then process the samples using Liquid-based cytology, which helps evenly distribute cells and reduces interference from blood, mucus, or inflammatory cells that may affect the test results.
Then, technicians or pathologists examine the cell characteristics to see if there is inflammation, infection, or changes that may develop into cancer.
Advantages of ThinPrep
- Detects cellular abnormalities at an early stage
- More accurate than traditional Pap smear because cells are evenly distributed
- Can detect some infections such as bacterial, fungal, or parasitic infections
Limitations
- Detects only cellular abnormalities and cannot directly identify the cause
- May result in false positives or false negatives.
- Therefore, ThinPrep requires expertise in interpretation and may miss minor changes if the collected cells are insufficient or of poor quality.
In-depth! What is HPV DNA Test?
HPV DNA Test is a test that detects the genetic material (DNA) of the HPV (Human Papillomavirus) virus, which is the main cause of cervical cancer.
How it is done
Cell samples are collected from the cervix similarly to ThinPrep, then tested for HPV DNA, especially high-risk types that cause cancer, using a technology called PCR (Polymerase Chain Reaction), which can amplify and detect viral DNA accurately even in very small amounts.
Advantages of HPV DNA Test
- Detects the direct cause of cervical cancer
- Highly sensitive and can accurately identify those at risk
- Helps plan effective follow-up or treatment
Limitations
- Since HPV infection is common and normal in sexually active women, especially young women, most bodies can clear the virus without causing problems. Therefore, a positive HPV test does not always mean cancer and may cause unnecessary anxiety.
- May lead to additional unnecessary tests or treatments in some cases.
Comparison between ThinPrep and HPV DNA Test
When comparing these two screening methods, each has different strengths and limitations.
| Aspect | ThinPrep | HPV DNA Test |
| Method | Collects cells from the cervix to detect cellular abnormalities | Detects HPV viral DNA in cervical cells |
| Main purpose | Detects cellular abnormalities that may be cancerous | Detects high-risk HPV strains that cause cancer |
| Detection timing | Detects abnormalities when cells begin to change | Detects virus before cellular changes occur |
| Accuracy | More accurate than traditional Pap smear, reducing false negatives | Highly accurate, can identify HPV strains |
| Limitations | Cannot directly identify HPV infection | HPV detection does not always mean cancer will develop |
| Suitable for | Sexually active women of all ages from 21 years old | Women aged 30 and above or high-risk groups |
| Screening frequency | Every 1-3 years (as recommended by doctors) | Every 3-5 years (if combined with ThinPrep and results are normal) |
| Cost | Lower or comparable to HPV DNA Test depending on the healthcare facility | Higher than ThinPrep |
| Chance of false negatives/positives | False negatives can occur due to poor sampling or misinterpretation
False positives can also occur |
Very few false negatives
False positives occur because the body clears HPV but the test remains positive |
For women aged 21-29 years:
It is recommended to have ThinPrep every 3 years. HPV DNA Test is not recommended in this group because HPV infection is common and usually clears on its own without causing problems.
For women aged 30-65 years:
There are three screening options: ThinPrep every 3 years, HPV DNA Test every 5 years, or both tests together (Co-testing) every 5 years.
Testing both is best!
Based on current studies and medical data, the best cervical cancer screening is to perform both tests together, called “Co-testing,” especially for women aged 30 and above.
Because Co-testing provides the most comprehensive and accurate information, increasing the chances of detecting cervical cancer and cellular abnormalities early, and helping doctors plan appropriate follow-up and treatment.
ThinPrep helps detect existing cellular changes, while HPV DNA Test helps assess future risk.
When both test results are normal, the confidence that cervical cancer will not develop in the next 5 years is as high as 99%, allowing the screening interval to be extended to 5 years.